PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-May-2025 Communiqué from the Annual General Meeting of AlzeCure Pharma on 14 May 2025 ACCESS Newswire
14-May-2025 Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited Medeze
14-May-2025 Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3 ACCESS Newswire
14-May-2025 Diabetes Injection Pens Market: Technological Advancements Set to Drive 7% CAGR Growth by 2028 MediTech Insights
14-May-2025 Coulter Partners places experienced R&D leader and biotech entrepreneur as CEO of Nuage Therapeutics Coulter Partners
14-May-2025 Autoinjectors Market to Grow at 14–16% CAGR, Driven by Chronic Diseases and Self-Administration by 2028 MediTech Insights
14-May-2025 Surgical Retractors Market: A 6-7% CAGR Growth Forecast Fueled by Advancements in Technology by 2028 MediTech Insights
14-May-2025 Global Patient Monitoring Devices Market: Shaping the Future of Healthcare with 8% CAGR by 2028 MediTech Insights
14-May-2025 Ligation Devices Market: The Impact of Minimally Invasive Surgeries and Projected 6-7% CAGR by 2028 MediTech Insights
14-May-2025 Global Serological Testing Market: How COVID-19 and Point-of-Care Diagnostics Are Fueling a 6-8% CAGR by 2028 MediTech Insights
14-May-2025 Nurses Continue to Name EHRs a Top Driver of Burnout and Resignation in 2025, Black Book Nurses' Week Survey ACCESS Newswire
14-May-2025 Desert Oasis Healthcare Leads the Way in Dementia Detection with Cutting-Edge Digital Screening Tool ACCESS Newswire
14-May-2025 Pacemakers Market to Grow at 3–4% CAGR, Driven by Innovation and Aging Population by 2028 MediTech Insights
14-May-2025 BioInvent Presents Additional CTCL Phase 2a Data for BI-1808 Monotherapy at EHA 2025 ACCESS Newswire
14-May-2025 BioInvent Announces Updated Phase 2a Triple Combination Arm Data of BI-1206, rituximab, and Calquence for the Treatment of Non-Hodgkin's Lymphoma ACCESS Newswire
14-May-2025 Faron Pharmaceuticals Ltd: Grant of Options ACCESS Newswire
14-May-2025 Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) Kaerus Bioscience
14-May-2025 Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results ACCESS Newswire
14-May-2025 Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates ACCESS Newswire
14-May-2025 Cognixion and Blackrock Neurotech Expand Access to Non-Invasive, Multi-Modal BCI Research with Axon-R ACCESS Newswire